All comparisons

Compare the evidence

Howmet vs Rocket Lab vs Centrus

Compare qualified manufacturing, mission delivery and enrichment expansion. Different industries and accounting measures make this a framework comparison, not a financial league table.

Read horizontally within each row. Product ratings, planned capacity, completed deliveries and current financials describe different stages.

On narrow screens, scroll the comparison horizontally. Each figure keeps its period, accounting definition and source. GAAP cash flow, adjusted margins, segment gross profit and EBITDA are not interchangeable.

Howmet vs Rocket Lab vs Centrus: capacity, delivery, economics and evidence boundaries
Research dimensionHowmet AerospaceHWM · Checked 2026-10-04Rocket LabRKLB · Checked 2026-10-04Centrus EnergyLEU · Checked 2026-10-04
Industrial role

Engineered aerospace metal components

Launch services and spacecraft infrastructure

Uranium enrichment and HALEU expansion

Constraint to test

Qualified casting and manufacturing throughput

Reliable mission delivery as contracted demand grows

Scaling licensed enrichment into commercial deliveries

Reported evidence and sources

Howmet lists engine-product operations including investment casting and alloy production.

Rocket Lab disclosed a 20-mission Synspective agreement and a completed Electron mission in September.

Centrus disclosed a DOE contract for enrichment expansion and intentions to transition its HALEU cascade toward commercial operation.

Capacity and delivery
  • Engine Products added approximately 485 net staff during Q2. Staffing is a ramp input, not a disclosed increment of qualified casting output. Source ↗
  • Management expects higher capital requirements in 2027; casting yields and plant-level annual output are not quantified in this release. Source ↗
  • Electron had completed 97 missions by September 26. A cumulative mission count does not establish an annual sustainable launch rate. Source ↗
  • The September 30 Synspective agreement covers 20 future missions scheduled for 2028–2031; financial terms are undisclosed. Bookings are distinct from completed missions. Source ↗
  • The Q2 release targeted delivery of Neutron to the launch pad in Q4 2026. That target is not a completed launch or operational medium-lift capacity. Source ↗
  • The July DOE award provides $900m for expansion, with new enrichment production targeted for 2029. Commercial transition plans are distinct from operating commercial output. Source ↗
  • The planned initial expansion includes 12 metric tons of annual HALEU production capacity. Demonstration production exceeded 1,900 kg of HALEU UF6 cumulatively; this compound mass is not kg of uranium or an annual commercial output rate. Source ↗
  • The August release expects the first new centrifuge to be completed by year-end 2026. One centrifuge is not a commissioned production cascade. Source ↗
Reported economics
Engine Products revenue
$1,373m · +32% YoYQ2 2026 · Reported segment sales · Source ↗
Engine Products adjusted EBITDA / margin
$517m / 37.7%Q2 2026 · Non-GAAP segment measures · Source ↗
Group revenue / organic growth
$2,547m / +21% YoYQ2 2026 · GAAP revenue / Non-GAAP organic growth · Source ↗
Capital expenditures / free cash flow
$104m / $479mQ2 2026 · GAAP capex / company-defined FCF · Source ↗
Engine Products net headcount added
Approximately 485Q2 2026 · Reported quarterly staffing addition · Source ↗
Launch Services revenue / gross profit
$44.586m / $19.110mQ2 2026 · Reported segment measures · Source ↗
Space Systems revenue / gross profit
$189.480m / $65.466mQ2 2026 · Reported segment measures · Source ↗
Total backlog
$2,355.9m2026-06-30 · Contracted backlog; not revenue · Source ↗
Group operating loss
−$57.514mQ2 2026 · GAAP · Source ↗
Cash used in operations
$134.407mH1 2026 · GAAP cash outflow · Source ↗
LEU segment revenue / cost of sales
$153.4m / $101.8mQ2 2026 · Reported segment measures · Source ↗
Technical Solutions revenue / cost of sales
$22.7m / $24.4mQ2 2026 · Reported segment measures · Source ↗
Technical Solutions gross result
−$1.7mQ2 2026 · Calculated: revenue less cost of sales; not operating profit · Source ↗
SWU sold / average realized SWU price
−23% / +3% YoYQ2 2026 · Reported quarterly volume / price change · Source ↗
Contingent LEU and HALEU backlog
$3.0bnReported 2026-08-05 · Contingent; not guaranteed realized revenue · Source ↗
Evidence coverage

Primary-source operating or segment results; capacity evidence retains its stated stage.

Engine Products is the closest reported financial lens on engine components, but also includes defense and gas turbines. Its adjusted EBITDA margin cannot isolate casting scarcity, engine-program mix or qualified market share.

No quantified share of revenue attributable to the specific constraint. No evidence-strength score is assigned.

Primary-source operating or segment results; capacity evidence retains its stated stage.

Space Systems generated most Q2 revenue; launch and spacecraft economics must be followed separately. Segment gross profit excludes shared operating expenses and is not segment operating profit. Backlog includes delivery and execution risk.

No quantified share of revenue attributable to the specific constraint. No evidence-strength score is assigned.

Primary-source operating or segment results; capacity evidence retains its stated stage.

Most current revenue comes from the LEU segment, distinct from future HALEU expansion. Technical Solutions includes more than HALEU. Its calculated gross result excludes corporate costs; the $3.0bn contingent backlog is not current delivered enrichment capacity.

No quantified share of revenue attributable to the specific constraint. No evidence-strength score is assigned.
Counter-evidence
  • Engineered Structures revenue fell 13%, reflecting divestiture and product rationalization. Group growth is not uniform across manufacturing processes. Source ↗
  • Q2 Launch Services revenue declined from $46.646m to $44.586m YoY, while Space Systems grew. Total-company growth therefore does not prove accelerating launch throughput. Source ↗
  • H1 operating cash outflow was $134.407m. Financing proceeds improve liquidity but do not establish self-funded operations. Source ↗
  • Technical Solutions revenue fell 21% YoY, including a $5.9m decrease under the existing DOE HALEU operation contract, and costs exceeded segment revenue. Source ↗
  • SWU unit costs rose 13% YoY while average SWU prices rose 3%; a tight-supply narrative does not automatically imply wider realized margins. Source ↗
Next to monitor
  • Engine Products output, yields and OEM delivery acceptance
  • Hiring and 2027 capital spending versus incremental qualified capacity
  • Engine Products margins as engine spares, OEM and gas-turbine demand change
  • Timing and completed launches against the 20-mission Synspective agreement
  • Launch Services versus Space Systems revenue, gross profit and backlog conversion
  • Neutron hardware testing and launch-pad readiness; operating cash use
  • First new centrifuge completion versus a commissioned and licensed cascade
  • Funding, construction and 2029 enrichment-production milestones
  • Contingent contracts becoming firm deliveries; Technical Solutions gross result and SWU price-cost spread
What would weaken the case?
  • Qualified capacity growth normalizes lead times or pricing
  • OEM schedules slow or engine-spares demand eases
  • Hiring and capital spending fail to improve accepted output
  • Launch bookings fail to convert into reliable mission cadence
  • Spacecraft acceptance delays increase contract assets and cash use
  • Neutron readiness slips while operating spending grows
  • Funding, licensing or construction delays push deliveries beyond customer needs
  • Customer reactors defer fuel demand or contingent orders do not become firm
  • Alternative qualified enrichment expands faster; unfavorable SWU price-cost spreads persist

Open in Excel or another spreadsheet. Each entry preserves its source, date and accounting definition; research interpretations are labeled.

How to use this comparison

Start with the constraint, inspect the dated sources, then follow the company to monitor new evidence. A documented industrial role does not establish a shortage or an attractive share price.

This comparison uses open company research checked on the dates shown. Valuation and expected returns require a separate review.